Worsening cholestasis and possible cefuroxime-induced liver injury following "successful" therapeutic endoscopic retrograde cholangiopancreatography for a distal common bile duct stone: a case report

J Med Case Rep. 2016 Dec 21;10(1):371. doi: 10.1186/s13256-016-1123-0.

Abstract

Background: Cefuroxime very rarely causes drug-induced liver injury. We present a case of a patient with paradoxical worsening of jaundice caused by cefuroxime-induced cholestasis following therapeutic endoscopic retrograde cholangiopancreatography for a distal common bile duct stone.

Case presentation: A 51-year-old, previously healthy Sri Lankan man presented to our hospital with obstructive jaundice caused by a distal common bile duct stone. Endoscopic retrograde cholangiopancreatography with stone extraction, common bile duct clearance, and stenting failed to improve the cholestasis, with paradoxical worsening of his jaundice. A liver biopsy revealed features of drug-induced intrahepatic cholestasis. Although his case was complicated by an episode of cholangitis, the patient made a complete recovery in 4 months with supportive treatment and withdrawal of the offending drug.

Conclusions: This case highlights a very rare drug-induced liver injury caused by cefuroxime as well as our approach to treating a patient with paradoxical worsening of jaundice after therapeutic endoscopic retrograde cholangiopancreatography.

Keywords: Cefuroxime; Cholestasis; Drug-induced liver injury; ERCP.

Publication types

  • Case Reports

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / adverse effects*
  • Cefuroxime / administration & dosage*
  • Chemical and Drug Induced Liver Injury / diagnosis*
  • Cholangiopancreatography, Endoscopic Retrograde*
  • Cholestasis / diagnosis*
  • Cholestasis / therapy
  • Common Bile Duct / pathology
  • Humans
  • Jaundice, Obstructive / etiology*
  • Liver / pathology*
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Cefuroxime